Press Releases Year None2025202420232022202120202019201820172015 January 13, 2025 ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones January 13, 2025 ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations January 6, 2025 ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference January 3, 2025 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
OricPharma logo
